In this episode of IOL Radio, we speak with Dr Kenneth Tomkovich. Dr Tomkovich is the co-principal investigator of the ICE3 trial, which was designed to evaluate the safety and efficacy of breast cryoablation, enabling women older than 60 years with low-risk early-stage breast cancers to benefit from a nonsurgical treatment and to avoid the associated surgical risks. He is here to discuss the 3 year interim analysis, which was recently published in the Annals of Surgical Oncology.

Learn more about the ICE3 trial here.